NBIX Financials
Neurocrine Biosciences Inc - Financial statements & key metrics
Stock Price
$153.88
Market Cap
$13.21B
P/E Ratio
31.6
EPS
$4.19
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$2.36B
Gross Profit
-
Operating Income
-
Net Income
$341.30M
EPS (Diluted)
$3.29
Balance Sheet Highlights
Total Assets
$3.72B
Total Liabilities
$1.13B
Shareholders Equity
-
Cash & Equivalents
$233.00M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$595.40M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
30.1%
Net Margin
16.0%
ROE
15.0%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is NBIX revenue?
NBIX's most recent quarterly revenue was $2.36B. Annual revenue can be calculated by summing the four most recent quarters.
Is NBIX profitable?
NBIX reported a profit of $341.30M in the most recent quarter. The net profit margin is 16.0%.
What is NBIX market cap?
NBIX has a market capitalization of $13.21B, making it a large-cap stock.
Does NBIX have debt?
View NBIX's balance sheet for debt information.
What is NBIX cash flow?
Cash flow data is available in the full financial statements.